Divergent Progress For Chinese Developers Of COVID Antivirals, Vaccines
Factors Include Demand, New Strains
Some of China's makers of COVID-19 antivirals are fast-tracking neutralizing antibodies and peptide fusion inhibitors in clinical trials, while vaccine developers are embroiled in a tougher situation against the mutating coronavirus.
